Seroquel is a widely registered antipsychotic, marketed in 47 countries across both established and emerging healthcare markets. Its active ingredient is quetiapine, classified as an antipsychotic and grouped within the broader psycholeptic and psychoanaleptic categories used in international drug classification systems. For travellers and expatriates already familiar with the brand, this page is intended as a reference point for identifying the same medication across borders.
Quetiapine is prescribed in the management of psychosis, schizophrenia, and bipolar disorder. The structured indication list further down this page details the registered uses recognised across the regulatory authorities in the markets where Seroquel is sold, which can vary somewhat from one jurisdiction to the next.
Because Seroquel has such a broad international footprint, travellers and people relocating frequently encounter the same medication abroad — sometimes still labelled Seroquel, sometimes as a quetiapine-containing generic. Markets where the brand is registered include Brazil, Australia, China, Canada, and Finland, but packaging, available formulations, and prescription pathways differ considerably between countries. A pharmacist in the destination country can confirm whether a locally available quetiapine product corresponds to what the patient was previously taking.
Other medications in the antipsychotic class are sold in many of the same markets under different molecules and different brand names, although these are not interchangeable without clinical guidance. Continuity of antipsychotic therapy across a move or a long trip is a clinical matter rather than a pharmacy-counter decision: a healthcare provider familiar with the patient's history is the right person to oversee any substitution, dose adjustment, or change of brand.
Seroquel is prescribed in the management of psychosis, schizophrenia, and bipolar disorder. Its active ingredient belongs to the antipsychotic class, also categorised within the broader psycholeptic and psychoanaleptic groupings used in international drug classification systems. The structured indication block further down this page lists the registered uses recognised by national regulators in the markets where Seroquel is authorised.
Seroquel contains quetiapine, an antipsychotic also classified within the psycholeptic and psychoanaleptic categories. Quetiapine is the same molecule whether sold under the Seroquel brand or as a generic — internationally, the same active ingredient circulates under multiple commercial names, particularly in markets where the original patent has expired and several manufacturers produce quetiapine products in parallel.
Seroquel is registered in 47 countries spanning Europe, the Americas, Asia, Oceania, North Africa, and the Middle East. Examples include Brazil, Australia, China, Canada, Egypt, and Finland. If your country is not represented on this list, a local pharmacist can usually confirm whether quetiapine is available in that market under a different brand name or as a generic.
Quetiapine is sold under several brand names worldwide, particularly in markets where the original patent has expired and generic manufacturers have entered. Other medications within the broader antipsychotic class also exist, although they are not interchangeable without medical guidance — molecules within this class can have meaningfully different profiles. To identify a local quetiapine-containing product, search the active ingredient on Pill2Trip or ask a pharmacist in your country.
Yes. Seroquel is a prescription medication, and antipsychotic therapy is calibrated carefully to a patient's diagnosis, history, and concurrent medications. This matters particularly for travellers and people relocating between countries, since prescription pathways, available brands, and generic equivalents differ across regulatory systems. Any decision to start, stop, switch, or substitute quetiapine should be made together with a healthcare provider familiar with the patient.
